240 related articles for article (PubMed ID: 14658948)
1. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
Hoopes SP; Reimherr FW; Hedges DW; Rosenthal NR; Kamin M; Karim R; Capece JA; Karvois D
J Clin Psychiatry; 2003 Nov; 64(11):1335-41. PubMed ID: 14658948
[TBL] [Abstract][Full Text] [Related]
2. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
[TBL] [Abstract][Full Text] [Related]
3. Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
McElroy SL; Shapira NA; Arnold LM; Keck PE; Rosenthal NR; Wu SC; Capece JA; Fazzio L; Hudson JI
J Clin Psychiatry; 2004 Nov; 65(11):1463-9. PubMed ID: 15554757
[TBL] [Abstract][Full Text] [Related]
4. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.
McElroy SL; Arnold LM; Shapira NA; Keck PE; Rosenthal NR; Karim MR; Kamin M; Hudson JI
Am J Psychiatry; 2003 Feb; 160(2):255-61. PubMed ID: 12562571
[TBL] [Abstract][Full Text] [Related]
5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
7. Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa.
Dalai SS; Adler S; Najarian T; Safer DL
Contemp Clin Trials; 2018 Jan; 64():173-178. PubMed ID: 29038069
[TBL] [Abstract][Full Text] [Related]
8. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial.
Nickel C; Tritt K; Muehlbacher M; Pedrosa Gil F; Mitterlehner FO; Kaplan P; Lahmann C; Leiberich PK; Krawczyk J; Kettler C; Rother WK; Loew TH; Nickel MK
Int J Eat Disord; 2005 Dec; 38(4):295-300. PubMed ID: 16231337
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.
Claudino AM; de Oliveira IR; Appolinario JC; Cordás TA; Duchesne M; Sichieri R; Bacaltchuk J
J Clin Psychiatry; 2007 Sep; 68(9):1324-32. PubMed ID: 17915969
[TBL] [Abstract][Full Text] [Related]
10. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
Storey JR; Calder CS; Hart DE; Potter DL
Headache; 2001; 41(10):968-75. PubMed ID: 11903524
[TBL] [Abstract][Full Text] [Related]
11. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.
Faris PL; Kim SW; Meller WH; Goodale RL; Oakman SA; Hofbauer RD; Marshall AM; Daughters RS; Banerjee-Stevens D; Eckert ED; Hartman BK
Lancet; 2000 Mar; 355(9206):792-7. PubMed ID: 10711927
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topiramate in bulimia nervosa and binge-eating disorder: a systematic review.
Arbaizar B; Gómez-Acebo I; Llorca J
Gen Hosp Psychiatry; 2008; 30(5):471-5. PubMed ID: 18774432
[TBL] [Abstract][Full Text] [Related]
13. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
14. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.
Berlant J; van Kammen DP
J Clin Psychiatry; 2002 Jan; 63(1):15-20. PubMed ID: 11838620
[TBL] [Abstract][Full Text] [Related]
15. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial.
Johnson BA; Ait-Daoud N; Akhtar FZ; Ma JZ
Arch Gen Psychiatry; 2004 Sep; 61(9):905-12. PubMed ID: 15351769
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.
Baldaçara L; Cogo-Moreira H; Parreira BL; Diniz TA; Milhomem JJ; Fernandes CC; Lacerda AL
J Clin Psychiatry; 2016 Mar; 77(3):398-406. PubMed ID: 27046312
[TBL] [Abstract][Full Text] [Related]
17. Topiramate for the treatment of cocaine addiction: a randomized clinical trial.
Johnson BA; Ait-Daoud N; Wang XQ; Penberthy JK; Javors MA; Seneviratne C; Liu L
JAMA Psychiatry; 2013 Dec; 70(12):1338-46. PubMed ID: 24132249
[TBL] [Abstract][Full Text] [Related]
18. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
Privitera M; Fincham R; Penry J; Reife R; Kramer L; Pledger G; Karim R
Neurology; 1996 Jun; 46(6):1678-83. PubMed ID: 8649569
[TBL] [Abstract][Full Text] [Related]
19. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
20. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
McElroy SL; Kotwal R; Guerdjikova AI; Welge JA; Nelson EB; Lake KA; D'Alessio DA; Keck PE; Hudson JI
J Clin Psychiatry; 2006 Dec; 67(12):1897-906. PubMed ID: 17194267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
